InvaGen Pharmaceuticals, Inc. sold $3.0M of ATXI
owner at AVENUE THERAPEUTICS, INC.. 388,888 shares at an average of $7.71, traded Oct 11, 2022, filed Oct 13, 2022.
Score components
- +12Role10% owner
- +25Trade size$3.0M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-22-108589, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 11, 2022 | SOpen-market sale Common Stock, par value $0.0001 per share | -388,888 | $7.71 | $3.0M | 0 | Oct 13, 2022 |
Related signals
Other insiders at AVENUE THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | ATXIsell AVENUE THERAPEUTICS, INC. | Neil Herskowitz director | $46 23 shares | -19% | |
| 15Weak | ATXIsell AVENUE THERAPEUTICS, INC. | Jay D Kranzler director | $137 61 shares | -10% | |
| 33Weak | ATXIbuy AVENUE THERAPEUTICS, INC. | Jay D Kranzler director | $1,250 500 shares | +417% | |
| 41Moderate | ATXIsell AVENUE THERAPEUTICS, INC. | Robert L Davidow owner | $87k 617,000 shares | -65% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.